Hoffmann-la Roche Inc. Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Hoffmann-la Roche Inc.
Patents: | 0 |
Tradenames: | 3 |
Ingredients: | 3 |
BLAs: | 3 |
Biologic Drugs for Hoffmann-la Roche Inc.
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | 1986-06-04 | ⤷ Try a Trial | |
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 1997-12-10 | ⤷ Try a Trial | |
Hoffmann-la Roche Inc. | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 2002-10-16 | ⤷ Try a Trial | |
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 2004-06-04 | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |